• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Wellgistics Health Inc.

    11/14/25 4:15:04 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care
    Get the next $WGRX alert in real time by email
    NT 10-Q 1 formnt10-q.htm NT 10-Q

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

    NOTIFICATION OF LATE FILING

     

    Commission File Number: 001-42530

     

    (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR
       
      For Period Ended: September 30, 2025

     

      ☐ Transition Report on Form 10-K
      ☐ Transition Report on Form 20-F
      ☐ Transition Report on Form 11-K
      ☐ Transition Report on Form 10-Q
      ☐ Transition Report on Form N-SAR
         
      For the Transition Period Ended: _______________

     

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

     

    PART I — REGISTRANT INFORMATION

     

    WELLGISTICS HEALTH, INC.

    (Full Name of Registrant)

     

    Not Applicable

    (Former Name if Applicable)

     

    3000 Bayport Drive, Suite 950

    (Address of Principal Executive Office (Street and Number))

     

    Tampa, FL 33607

    (City, State and Zip Code)

     

     

     

     

     

     

    PART II — RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

     

      (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    ☒ (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
      (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III— NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period.

     

    Wellgistics Health, Inc. (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the period ended September 30, 2025 (the “Quarterly Report”).

     

    On November 11, 2025, the Company’s independent registered public accounting firm, UHY LLP, resigned. The Company’s board of directors is in the process of approving a new independent registered public accounting firm and expects to file a Current Report on Form 8-K regarding the resignation of UHY LLP and the engagement of the new auditor within the time period required by SEC rules.

     

    As a result of the resignation of the Company’s former auditor and the transition to a new independent registered public accounting firm, additional time is required to complete the review and finalization of the financial statements and related disclosures required to be included in the Quarterly Report. Accordingly, the Company is unable to file the Quarterly Report within the prescribed time period without unreasonable effort or expense.

     

    The Company is working diligently to complete the Quarterly Report as promptly as possible and currently anticipates filing it on or before the fifth calendar day following the prescribed due date, as permitted by Rule 12b-25. 

     

    PART IV — OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification

     

      Prashant Patel   (844)   203-6092
      (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

     

    ☒ Yes ☐ No

     

    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

    ☐ Yes ☒ No

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     

     

     

    WELLGISTICS HEALTH, INC.

    (Name of Registrant as Specified in Charter)

     

    Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

     

    Date: November 14, 2025 By: /s/ Prashant Patel
      Name: Prashant Patel
      Title: President

     

     

     

    Get the next $WGRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WGRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $WGRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Doss Howard A.

    3 - Wellgistics Health, Inc. (0002030763) (Issuer)

    10/24/25 2:27:17 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    SEC Form 3 filed by new insider Fell Donald G.

    3 - Wellgistics Health, Inc. (0002030763) (Issuer)

    10/21/25 3:04:46 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    SEC Form 3 filed by new insider Lee Steven Dale

    3 - Wellgistics Health, Inc. (0002030763) (Issuer)

    10/14/25 4:45:31 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    SEC Filings

    View All

    Wellgistics Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Wellgistics Health, Inc. (0002030763) (Filer)

    12/8/25 4:30:53 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Wellgistics Health, Inc. (0002030763) (Filer)

    12/5/25 4:05:28 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Wellgistics Health, Inc. (0002030763) (Filer)

    11/26/25 4:30:48 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Datavault AI Licenses Patents Covering Digital Ledger-Enabled Smart Contracts for Commercial Prescription Drug Distribution Industry to Wellgistics Health

    § Exclusive licensing arrangement positions Wellgistics to become the Web 3.0 Health Information Data Transfer Leader in the $634 billion Prescription Drug Industry[1] §  Implementation of Wellgistics' proprietary EinsteinRx AI hub anticipated to facilitate automated prescription fulfillment optimization for manufacturers, pharmacies, physicians, patients, and payers §  Datavault's enabling IP provides smart contracts barrier to entry in the $4.9 trillion US healthcare market[2] § Wellgistics PharmacyChain ‘Health Data Railroad' is the culmination of its revolutionary, Web 3.0 integrated smart contracts distribution infrastructure §  PwC estimates $1 trillion opportunity to shift healthc

    11/25/25 4:07:34 PM ET
    $DVLT
    $WGRX
    Semiconductors
    Technology
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Enters into Smart Contract Services Agreement with DataVault AI to Develop Patented PharmacyChain(TM) Manufacturer-to-Patient Blockchain-Enabled Tracking & Dispensing Platform for Prescription Drug Market

    Powered by DataVault AI's High-Performance Computing & Information Exchange, Data Monetization for Traditional and Compound Pharmacies is Set to Become a Reality in the $639 Billion Prescription Drug Market, with Beta Testing Expected in First Half of 2026Tampa, Florida and Philadelphia, Pennsylvania--(Newsfile Corp. - October 27, 2025) - Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that it has entered into a software as a service (SAAS) agreement with DataVault AI, Inc. (NASDAQ:DVLT) ("DataVault"), a pioneering technology company leading the way i

    10/27/25 9:42:00 AM ET
    $DVLT
    $WGRX
    Semiconductors
    Technology
    Other Pharmaceuticals
    Health Care

    DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes

    BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- DataVault AI, Inc. ("DataVault") (NASDAQ:DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts ("PharmacyChain™") into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry. The goal of the partnership will be to seek to fully digitize t

    10/22/25 6:05:00 AM ET
    $DVLT
    $WGRX
    Semiconductors
    Technology
    Other Pharmaceuticals
    Health Care

    $WGRX
    Financials

    Live finance-specific insights

    View All

    Wellgistics Health Secures $50M ELOC facility for XRP Treasury Reserve & Real-Time Payments Infrastructure and other general ops

    Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity

    5/8/25 9:00:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative

    Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity

    5/8/25 7:05:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care